news

/news

Cancer Drugs Fund adds Roche, Celgene and Exelixis drugs

Three new drugs have been added to the Cancer Drugs Fund (CDF) in a move NHS England says could benefit 900 patients per year. The Fund will add new NHS coverage in England for Roche’s Avastin (bevacizumab), Celgene’s Abraxane (albumin bound paclitaxel) and Exelixis’ Cometriq (cabozantinib). The CDF provides special funding for drugs that have [...]

By | January 3rd, 2017|Comments Off on Cancer Drugs Fund adds Roche, Celgene and Exelixis drugs

AstraZeneca launches delivery service for Nexium

AstraZeneca has expanded its direct-to-patient delivery service in the US, adding a new Nexium Direct programme that allows patients to order medication online through the brand website. The delivery service is tied to AstraZeneca’s www.purplepill.com website and builds on the service the company launched in 2011 for its breast cancer drug Arimidex. Patients need a doctor’s prescription [...]

By | October 13th, 2016|Comments Off on AstraZeneca launches delivery service for Nexium

Pfizer gains ground in cholesterol antibody chase

Pfizer has put on a late spurt in the race to bring a PCSK9 blocker class to market, reporting positive phase 2b data for bococizumab, which has now entered late-stage testing. Results from the 24-week study show that bococizumab (RN316) was significantly better than placebo in reducing elevated LDL-cholesterol, a major risk factor for cardiovascular [...]

By | October 5th, 2016|0 Comments